The Motley Fool··Jeff SiegelThree Biotech Plays Emerge as FDA Activity, Rate Stability Drive Sector Interest
Biotech stocks $SDGR, $SRPT, and $NRXP gain attention as FDA activity accelerates and interest rates stabilize, offering varied risk-reward profiles.
NRXPNRXPWSRPTSDGRFDA approvalgene therapy